Cardiology

Evinacumab cuts cholesterol levels by half in patients with HoFH

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled ...

Diseases, Conditions, Syndromes

Nigeria reports first coronavirus death

Nigeria on Monday reported its first death from coronavirus as confirmed cases of infections in Africa's most populous nation climbed further.

Diseases, Conditions, Syndromes

Coronavirus: Rio's favelas prepare for the worst

Disadvantaged by poverty, unsanitary housing and poor to non-existent health services, the people of Rio de Janeiro's teeming favelas are preparing for the worst when the coronavirus takes a grip on Brazil.

Diseases, Conditions, Syndromes

Coronavirus SARS-CoV2: BESSY II data accelerate drug development

A coronavirus is keeping the world in suspense. SARS-CoV-2 is highly infectious and can cause severe pneumonia with respiratory distress (COVID-19). Scientists are doing research in order to prevent the viruses from multiplying. ...

Diseases, Conditions, Syndromes

Nigeria moves coronavirus patient for better health care

Nigerian health authorities said Saturday an Italian who tested positive for the coronavirus in Lagos, the first case in Nigeria, has been relocated for better care, a health official said.

Medications

Mayo Clinic Minute: Statins plus lifestyle equals healthy life

Statins are medications that reduce your risk of a heart attack and stroke by lowering your cholesterol. Dr. Stephen Kopecky, a Mayo Clinic cardiologist, says people should combine statins with a heart-healthy lifestyle to ...

page 31 from 40